Altered lipid parameters in patients infected with Entamoeba histolytica, Entamoeba dispar and Giardia lamblia

British Journal of Biomedical Science

Volumn 62, Issue 2, 2005, Pages 63-65

  Bansal, D ^a   Bhatti, H S ^a   Sehgal, Rakesh ^a,b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Entamoeba dispar; Entamoeba histolytica; Giardia lamblia; Lipids

Indexed keywords

CHOLESTEROL; HEXOKINASE; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN;

ARTICLE; CONTROLLED STUDY; ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GIARDIA LAMBLIA; HUMAN; ISOENZYME ANALYSIS; LIVER AMEBIASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTOZOAL INFECTION; SEROLOGY;

ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA; GIARDIA INTESTINALIS;

EID: 21744434187     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2005.11732686     Document Type: Article

References (13)

1. Walsh AL. Prevalence in Entamoeba histolytica infection. In: Ravdin JI, ed. Atnoebiasis: human infection by Entamoeba histolytica. New York: John Wiley, 1988: 93-105.
2. Adam RD. The biology of Giardia spp. Microbiol Rev 1991; 55: 706-32.
3. Lujan HD, Mowatt MR, Nash TE. The mechanisms of Giardia lamblia differentiation into cysts. Microbiol Mol Biol Rev 1997; 61: 294-304.
4. Gillin FD, Reiner DS, McCaffery M. Cell biology of the primitive eukaryote Giardia lamblia. Annu Rev Microbiol 1996; 50: 679-705.
5. Martinez-Palomo A, Martinez Baez M. Selective primary health care; strategies for control of disease in the developing world. X. Amoebiasis Rev Infect Dis 1985; 5: 1093-102.
6. Sharma R. Effect of cholesterol on the growth and virulence of E. histolytica. Trans R Soc Trop Med Hyg 1959; 53: 278.
7. Singh BN, Srivastava RVN, Dutta GP. Virulence of strain of E. histolytica to rats and the effect of cholesterol, rat caecal and hamster liver passage on the virulence of non-invasive strains. Indian J Exp Biol 1971; 9: 21.
8. Vinayak VK, Chakravarti RN, Agarwal KC, Naik SR, Chuttani PN. Pathogenicity of Entamoeba histolytica - effect of cholesterol on the virulence of strains of amoebae. Indian J Med Res 1978; 67: 543-52.
9. Gargouri ML. Utilisation du cholesterol bans l'amibiase experimental du cobaye. Ann Parasitol Hum Comp 1967; 42: 399.
10. Mata-Cardenas BD, Morales-Vallarta M, Vargas-Villarreal J, Said-Fernandez S. PACSR*: a serum replacement for axenic cultivation of Entamoeba histolytica. Trans R Soc Trop Med Hyg 1996; 90: 586.
11. Vohra H, Bhatti HS, Ganguly NK, Mahajan RC. Virulence of pathogenic and non-pathogenic zymodemes of Entamoeba histolytica. Trans R Soc Trop Med Hyg 1989; 83: 648-50.
12. Haque R, Ali IKM, Akther S, William A, Petri JR. Comparison of PCR, isoenzyme analysis and antigen detection for diagnosis of Entamoeba histolytica infection. J Clin Microbiol 1998; 36: 449-52.
13. k regulates Giardia encystations process. Mol Cell Biochem 2001; 225: 167-9.